PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Visiongain

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Magnetic Resonance Imaging Systems Market to Reach $10.4bn by 2022 Predicts Visiongain - A new report by visiongain, a London-based business information provider, predicts that the global market for MRI systems will be worth $10.4bn by 2022. The market generated sales of $4.0bn in 2010 - Visiongain.com
Magnetic Resonance Imaging Systems Market to Reach $10.4bn by 2022 Predicts Visiongain

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/03/30 - A new report by visiongain, a London-based business information provider, predicts that the global market for MRI systems will be worth $10.4bn by 2022. The market generated sales of $4.0bn in 2010 - Visiongain.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The medical device industry has witnessed explosive growth in recent years. According to visiongain estimates, the global market was worth $236.1bn in 2010. Much of this growth is linked to the rising prevalence of a number of diseases worldwide; most notably in cardiac and neurological systems. This has fuelled a strong demand for technically advanced medical and diagnostic imaging devices, capable of providing accurate and detailed diagnoses, which can allow earlier and therefore potentially life-saving, medical intervention. Magnetic Resonance Imaging (MRI) represents the fastest growing segment of the global medical imaging market, where in response to patient demand, hospitals and healthcare care providers around the world are upgrading their older equipment with state of the art systems.

Hemant Mistry, healthcare industry analyst, says: “The MRI market continues to grow despite the global economic uncertainty and healthcare cutbacks being witnessed in a number of countries worldwide. This is due in part to emerging clinical applications and the new trend of hybrid technology, which provides systems with the ability to capture images both anatomically and functionally. For example, the combination of MRI with other imaging modalities, such as Positron Emission Tomography (PET) scans, has allowed for the imaging of cartilage damage, previously thought unreliable. Indeed, experts claim this technique could replace the use of arthroscopy in the near future. These factors, coupled with the worldwide aging population, increased applications and technological innovations, will drive the growth of the MRI systems market, which is poised to become the largest segment of the global medical imaging devices market.’

Visiongain’s research also suggests that the world MRI systems market may benefit from globalisation. While developed markets such as the US and Western Europe are steadily reaching saturation, the focus on new product development is likely to be in emerging countries, such as India and China. The emerging countries offer huge opportunities, owing to the low density of MRI scanners in these regions. Also, as a result of these countries’ rapidly growing economies, there is an increased focus towards healthcare spending from their respective governments. Furthermore, growth in these countries will trigger increased awareness and adoption globally, which will further strengthen the global market.

Visiongain predicts that the MRI systems market will grow rapidly to 2022. The future of the MRI systems market appears promising and has significant potential for growth and investment with the increasing demand for improved diagnostic and medical imaging equipment. This new report adds to visiongain’s wide range of analytical reports in healthcare and other industry areas.

For sample pages and further information concerning the visiongain report Magnetic Resonance Imaging (MRI) Systems: Global Market Outlook 2012-2022 please visit the website/.

About visiongain
Visiongain (visiongain.com) is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Visiongain

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Magnetic Resonance Imaging Systems Market to Reach $10.4bn by 2022 Predicts Visiongain

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Visiongain |
Publisher Contact: Sara Peerun - Visiongain.com 
+44(0)20 7336 6100 sara.peerun[.]visiongainglobal.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Visiongain securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Visiongain / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)